PMID- 32962295 OWN - NLM STAT- MEDLINE DCOM- 20201204 LR - 20201214 IS - 1660-4601 (Electronic) IS - 1661-7827 (Print) IS - 1660-4601 (Linking) VI - 17 IP - 18 DP - 2020 Sep 20 TI - Increased Mortality Risk in People with Type 2 Diabetes Mellitus in Lithuania. LID - 10.3390/ijerph17186870 [doi] LID - 6870 AB - This retrospective cohort study aimed to analyze overall and cause-specific mortality risk in people with type 2 diabetes mellitus (T2DM) in Lithuania. Information on the diagnosis of T2DM and glucose-lowering medication was obtained from the National Health Insurance Fund database, causes of death-from death certificates. Sex, age, and calendar period-standardized mortality ratios (SMRs) were calculated. In addition, 89,512 patients were followed-up between 2010 and 2017, contributing to the observation period of 592,321 person-years. Overall mortality risk was increased for both sexes (overall SMR = 1.35, 95% confidence interval (CI) 1.34-1.37). Greatest mortality risk was in the age group of 40-49 years at diabetes diagnosis (SMR = 1.68, 95% CI 1.60-1.76) and among those who had died before the age of 50 (SMR = 22.04, 95% CI 18.82-25.81). Patients treated with insulin only had the highest SMR (2.43, 95% CI 2.32-2.55). Mortality risk increased with increasing diabetes duration and was higher in women in all these groups. The highest cause-specific SMRs were infection-related causes (SMR = 1.44), particularly septicemia (SMR = 1.78), diseases of the circulatory system (SMR = 1.42), especially ischemic heart (SMR = 1.46) and cerebrovascular diseases (SMR = 1.38), as well as diseases of the digestive system (SMR = 1.35). Cancer mortality risk was elevated for women (SMR = 1.13), but not for men (SMR = 0.93). In conclusion, people with T2DM had an excess mortality risk, which was higher in women compared to men, younger people, in those who were diagnosed with T2DM at a younger age, had longer diabetes duration, and who required treatment with insulin. FAU - Linkeviciute-Ulinskiene, Donata AU - Linkeviciute-Ulinskiene D AUID- ORCID: 0000-0003-1168-2003 AD - Institute of Biomedical Sciences, Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, Vilnius University, Ciurlionio g. 21, 03101 Vilnius, Lithuania. FAU - Kaceniene, Auguste AU - Kaceniene A AD - Laboratory of Cancer Epidemiology, National Cancer Institute, P. Baublio g. 3b, 08406 Vilnius, Lithuania. FAU - Dulskas, Audrius AU - Dulskas A AD - Laboratory of Cancer Epidemiology, National Cancer Institute, P. Baublio g. 3b, 08406 Vilnius, Lithuania. AD - Department of Abdominal and General Surgery and Oncology, National Cancer Institute, Santariskiu g. 1, 08406 Vilnius, Lithuania. FAU - Patasius, Ausvydas AU - Patasius A AUID- ORCID: 0000-0003-3874-2723 AD - Laboratory of Cancer Epidemiology, National Cancer Institute, P. Baublio g. 3b, 08406 Vilnius, Lithuania. AD - Institute of Health Sciences, Faculty of Medicine, Vilnius University, Ciurlionio g. 21, 03101 Vilnius, Lithuania. FAU - Zabuliene, Lina AU - Zabuliene L AD - Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Santariskiu g. 2, 08406 Vilnius, Lithuania. FAU - Smailyte, Giedre AU - Smailyte G AUID- ORCID: 0000-0001-8365-543X AD - Laboratory of Cancer Epidemiology, National Cancer Institute, P. Baublio g. 3b, 08406 Vilnius, Lithuania. AD - Institute of Health Sciences, Faculty of Medicine, Vilnius University, Ciurlionio g. 21, 03101 Vilnius, Lithuania. LA - eng PT - Journal Article DEP - 20200920 PL - Switzerland TA - Int J Environ Res Public Health JT - International journal of environmental research and public health JID - 101238455 SB - IM MH - Adult MH - Cause of Death MH - Cohort Studies MH - *Diabetes Mellitus, Type 2/complications/mortality MH - Female MH - Humans MH - Lithuania/epidemiology MH - Male MH - Middle Aged MH - Mortality MH - Retrospective Studies PMC - PMC7559991 OTO - NOTNLM OT - mortality OT - population study OT - retrospective cohort study. OT - standardized mortality ratio OT - type 2 diabetes mellitus COIS- The authors declare no conflict of interest. EDAT- 2020/09/24 06:00 MHDA- 2020/12/15 06:00 PMCR- 2020/09/01 CRDT- 2020/09/23 01:03 PHST- 2020/07/12 00:00 [received] PHST- 2020/09/15 00:00 [revised] PHST- 2020/09/18 00:00 [accepted] PHST- 2020/09/23 01:03 [entrez] PHST- 2020/09/24 06:00 [pubmed] PHST- 2020/12/15 06:00 [medline] PHST- 2020/09/01 00:00 [pmc-release] AID - ijerph17186870 [pii] AID - ijerph-17-06870 [pii] AID - 10.3390/ijerph17186870 [doi] PST - epublish SO - Int J Environ Res Public Health. 2020 Sep 20;17(18):6870. doi: 10.3390/ijerph17186870.